Wednesday, July 8, 2026

biotech · Atopic Dermatitis · Moderate to Severe Atopic Dermatitis · KYMR

Kymera Therapeutics

Kymera Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

500 North Beacon Street, 4th Floor, Watertown, MA 02472, US HQ
2016 Founded
289 Employees
Public company Type
KYMR · NYSE Ticker
Company details
Status
Public
HQ
500 North Beacon Street, 4th Floor, Watertown, MA 02472, US
Founded
2016
Employees
289
Programs
12
Drugs
6
Patents
29
Intelligence · Clinical Trials

Kymera Therapeutics clinical trials

Registry index of 13 ClinicalTrials.gov studies linked to Kymera Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Kymera Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Kymera Therapeutics.

  1. KT621-AS-202 — Phase 2

    Clinical update
  2. KT621-AD-201 — Phase 2

    Clinical update
  3. KT-474/Placebo — Phase 1

    Clinical update
  4. KT-621 — Phase 2

    Clinical update
  5. KT-621 — Phase 2

    Clinical update
  6. SAR444656 (KT-474) — Phase 2

    Clinical update
  7. SAR444656 (KT-474) — Phase 2

    Clinical update
  8. KT-253 — Phase 1

    Clinical update

Trial registry

13 studies